PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 142 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,852,372 | -39.6% | 2,449,183 | 0.0% | 15.05% | -28.4% |
| Q2 2023 | $67,646,434 | +20.1% | 2,449,183 | 0.0% | 21.00% | +14.6% |
| Q1 2023 | $56,331,209 | +210712.5% | 2,449,183 | 0.0% | 18.32% | +135.7% |
| Q4 2022 | $26,721 | -99.9% | 2,449,183 | 0.0% | 7.77% | +27.9% |
| Q3 2022 | $20,647,000 | +6.6% | 2,449,183 | 0.0% | 6.08% | +22.8% |
| Q2 2022 | $19,373,000 | -66.6% | 2,449,183 | 0.0% | 4.95% | -54.9% |
| Q1 2022 | $57,997,000 | -30.8% | 2,449,183 | 0.0% | 10.96% | +15.0% |
| Q4 2021 | $83,762,000 | +93.0% | 2,449,183 | 0.0% | 9.54% | +150.5% |
| Q3 2021 | $43,400,000 | – | 2,449,183 | – | 3.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |